N-acetylcysteine in experimental and clinical acute lung injury.
about
Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndromeOxygen-sensing mechanisms and the regulation of redox-responsive transcription factors in development and pathophysiologyN-acetylcysteine synergizes with oseltamivir in protecting mice from lethal influenza infectionDesign, synthesis and properties of novel powerful antioxidants, glutathione analogues.Glutathione in gingival crevicular fluid and its relation to local antioxidant capacity in periodontal health and diseaseAssociation of Toll-like receptor signaling and reactive oxygen species: a potential therapeutic target for posttrauma acute lung injury.Clinical trials of immunomodulatory therapies in severe sepsis and septic shock.The role of donor chronic alcohol abuse in the development of primary graft dysfunction in lung transplant recipients.Redox/ROS regulation of lipopolysaccharide-induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-alpha biosynthesis.Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-κB and Activating HO-1/Nrf2 Pathways.Anti-inflammatory effects of Myrtol standardized and other essential oils on alveolar macrophages from patients with chronic obstructive pulmonary disease.Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.N-Acetyl-l-cysteine effects on multi-species oral biofilm formation and bacterial ecology.Amifostine reduces lung vascular permeability via suppression of inflammatory signallingOxidation of plasma cysteine/cystine redox state in endotoxin-induced lung injuryChronic ethanol ingestion impairs alveolar type II cell glutathione homeostasis and function and predisposes to endotoxin-mediated acute edematous lung injury in rats.Advances in peripheral nerve regeneration.Interleukin-1-mediated acute lung injury and tolerance to oxidative injury.Role of free radicals and antioxidants in the pathogenesis of the inflammatory periodontal diseases.Radical approach to the acute respiratory distress syndrome.Hyaluronan production in vitro by fetal lung fibroblasts and epithelial cells exposed to surfactants of N-acetylcysteine.Reactive oxygen species and antioxidants in inflammatory diseases.N-acetylcysteine protects striated muscle in a model of compartment syndrome.Inhibitory effects of N-acetylcysteine on superoxide anion generation in human polymorphonuclear leukocytes.Effect of abdominal trauma on hemorrhagic shock-induced acute lung injury in rats.The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock.Nickel sulfate induced apoptosis via activating ROS-dependent mitochondria and endoplasmic reticulum stress pathways in rat Leydig cells.Protective effects of N-acetylcysteine on cyclosporine-A-induced nephrotoxicity.Protective effects of N-acetylcysteine on the peroxidative changes of rat lungs exposed to inhalation of thinners.N-acetylcysteine abrogates acute lung injury induced by endotoxin.N-acetylcysteine protects from glutathione depletion in rats exposed to hyperoxia.The effect of N-acetylcysteine on total serum anti-oxidant potential and urinary albumin excretion in critically ill patients.Effects of N-acetylcysteine on bacterial clearance.N-acetylcysteine modifies cis-dichlorodiammineplatinum-induced effects in bladder cancer cells.
P2860
Q24246217-C55C0FAD-F47D-4694-B90D-3A25C9AB4B10Q24802444-F44309F9-17B6-416D-BF26-F2544440E4B4Q28236065-D2E05350-A89D-4D30-9A0F-1251DB7A19F6Q33288138-E943EA20-8C0C-41E1-A94E-21A18F6F1E63Q33919085-3F713831-0263-4542-99D3-10FD01FBFC6FQ34035581-4C8BDCB1-8D90-4FF3-BCA0-1B49AFE7F488Q34577529-1C3AF1A8-C450-4C38-BE05-0A978D2EDA93Q35033561-751730CE-94FC-47EA-814E-9BAB189E9DFAQ35044016-29EE5497-58B8-4592-BA8D-04231A33852CQ36372450-BB84B10B-DFDE-4093-B9C9-265796D0E25DQ36464070-A5BCBE3C-4713-4E01-9BAD-DC9DFBFB2134Q36467694-CAE6C2D8-7265-4698-8568-8ED4B9AABF25Q36469928-B7EC7976-8E50-46DB-A09A-C6B3BEDACB4BQ36866297-DD928942-9031-43D7-97C7-3931D738C4DDQ37023323-37C66B1D-EFC0-4878-ABB0-AFDEC606CD8BQ37378157-A1426E2F-8DF3-4B5C-B60A-9F5E5A70F65CQ38161788-D0AF07B0-5D73-40BB-AEDC-A97707EC28C6Q40500079-AE1DA28E-89B7-4610-9BB2-A79F52559157Q40849481-36D356A0-EAAA-4FF8-9311-196D0AE6319CQ40897536-42BF6947-1162-479F-ADCA-C8D083B77092Q41136097-A34CF726-05AE-4C01-80B8-88F42D8652FFQ41493260-B89537E3-15ED-4803-88FF-D416299D39E8Q42053416-443030B9-81CA-4A6B-BE6C-7423A974E725Q42439297-EC8F17C7-742C-4B6E-8A86-0D84BFC2DBB8Q42726015-0BB0AE89-8E72-4C34-BA9D-5C1948D6011BQ43948790-64BCDFDF-0418-4D66-9BA4-0CA7F8FCB1D5Q46403800-B8BB3119-F922-4A17-98E3-8EB56D37ABA1Q46526962-1EF5B1F8-710F-4CAC-8690-297A8173DB6FQ46789947-F6C01DD8-B3F9-4D8A-9B1A-6397B3069D11Q46918488-0480AB4A-B3CB-4DC7-97FD-3F88AD35C6A6Q47857455-032679F4-0D89-484C-97E8-C116399D9A85Q51524613-C48B1B67-C568-42FA-8E90-0B7C2C141232Q54579820-50FA6D91-4EAB-474F-8DE2-7D6CA2FD1695Q55130339-5B95B942-DC0C-417E-B0E3-133A02126357
P2860
N-acetylcysteine in experimental and clinical acute lung injury.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
N-acetylcysteine in experimental and clinical acute lung injury.
@en
N-acetylcysteine in experimental and clinical acute lung injury.
@nl
type
label
N-acetylcysteine in experimental and clinical acute lung injury.
@en
N-acetylcysteine in experimental and clinical acute lung injury.
@nl
prefLabel
N-acetylcysteine in experimental and clinical acute lung injury.
@en
N-acetylcysteine in experimental and clinical acute lung injury.
@nl
P1476
N-acetylcysteine in experimental and clinical acute lung injury.
@en
P2093
Bernard GR
P304
P356
10.1016/0002-9343(91)90284-5
P407
P577
1991-09-01T00:00:00Z